Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
30 October, 2020 15:57 IST
Strides Pharma Science receives EIR for Bangalore unit
Source: IRIS | 06 Feb, 2019, 11.44AM
Rating: NAN / 5 stars.
Comments  |  Post Comment

Strides Pharma Science announced that its formulations facility (KRSG Gardens) in Bangalore which was inspected by the USFDA in August 2018 and November 2018, has received the Establishment Inspection Report (EIR), there by confirming the successful closure of the inspections. The inspection conducted in November 2018 had concluded with Zero 483 observations.

The flagship facility in Bangalore manufacturers tablets, capsules, liquids, creams ointments, sachets. The facility is the largest for company and supports several current and future products for the US markets.

Shares of the company declined Rs 10.1, or 2.4%, to trade at Rs 410.95. The total volume of shares traded was 97,058 at the BSE (10.46 a.m., Wednesday).

 Post Comment
Name Email
Security Code type    into this box
Related Articles
Persistent Systems - 29-Oct-2020 21:46
Persistent Systems - 29-Oct-2020 21:46
Titan Company quarterly earnings fall 37.81% - 29-Oct-2020 14:27
Titan Company quarterly net declines 37.81% - 29-Oct-2020 14:24
Titan Company quarterly profit drops 37.81% - 29-Oct-2020 13:58
Sensex falls 225 points - 28-Oct-2020 14:11
sensex trades lower - 28-Oct-2020 13:08
sensex opens higher - 28-Oct-2020 12:20
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer